S100A4 and disease of the tendon: While we have shown that knock-down of IRβ in S100a4-lineage cells is insufficient to recapitulate the phenotypes observed in obese/T2DM mice, future studies will be needed to determine if IRβ deletion, in the context of obesity, accelerates or slows tendinopathy development.